VOYA INVESTMENT MANAGEMENT LLC

Position in FTRE — Fortrea Holdings Inc.

CIK 1068837 ATLANTA, GA

Position in FTRE

as of Mar 31, 2026 · filed May 12, 2026 Compact

Position Value

$2,144,282

-$2,498,951 QoQ

Shares Held

227,631

-15.4% QoQ

Ownership

0.241%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Sep 2023

11 quarters on record

Voting authority Sole 0.ToString("F0")% Shared 100.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

VOYA INVESTMENT MANAGEMENT LLC holds $1,306,795,205 across 174 Biotechnology names. FTRE ranks #56 (0.2% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	REGN	Regeneron Pharmaceuticals, Inc.	349,912	$270,356,007
2	VRTX	Vertex Pharmaceuticals Inc / Ma	527,047	$235,347,566
3	ALNY	Alnylam Pharmaceuticals, Inc.	148,488	$49,130,223
4	PTGX	Protagonist Therapeutics, Inc	454,383	$47,891,967
5	ARWR	Arrowhead Pharmaceuticals, Inc.	656,129	$41,139,286
6	BBIO	BridgeBio Pharma, Inc.	538,980	$40,024,653
7	INSM	INSMED Inc	243,706	$39,850,804
8	SRRK	Scholar Rock Holding Corp	725,409	$35,661,105

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$2,144,282	227,631	-15.4%	Shares	Defined	2026-05-12
2025-12-31	$4,643,233	269,173	-17.6%	Shares	Defined	2026-02-12
2025-09-30	$2,749,137	326,501	-23.5%	Shares	Defined	2025-10-09
2025-06-30	$2,108,875	426,898	+40.5%	Shares	Defined	2025-08-14
2025-03-31	$2,294,452	303,901	+134.9%	Shares	Defined	2025-06-18
2024-12-31	$2,412,413	129,352	+781.1%	Shares	Defined	2025-05-02
2024-09-30	$293,600	14,680	-37.6%	Shares	Defined	2025-02-07
2024-06-30	$549,446	23,541	+9.5%	Shares	Defined	2025-02-07
2024-03-31	$862,729	21,493	+1.1%	Shares	Defined	2025-02-07
2023-12-31	$742,182	21,266	+17.4%	Shares	Defined	2025-02-07
2023-09-30	$517,850	18,113	—	Shares	Defined	2025-02-07
No filing history on record for this holder in this stock.